ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Jounce Therapeutics Receives FDA Clearance of Investigational NDA for Anti-CCR8 Antibody
June 17, 2021Jounce Therapeutics Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, announced the U.S. FDA's clearance of its Investigational New Drug (IND) application for JTX-1811 ...
Pharma Sources Insight January 2025
